Home › Funds › ALETHEA CAPITAL MANAGEMENT, LLC › KURA
ALETHEA CAPITAL MANAGEMENT, LLC position in KURA
KURA ONCOLOGY INC · Health Care
ALETHEA CAPITAL MANAGEMENT, LLC reported holding 2,175,838 shares of KURA (KURA ONCOLOGY INC) in its Q3 2026 13F filing — a position valued at US$23.3M, representing 11.86% of its reported portfolio and ranking #3 among its reported holdings. ALETHEA CAPITAL MANAGEMENT, LLC has disclosed KURA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How ALETHEA CAPITAL MANAGEMENT, LLC's KURA position evolved
ALETHEA CAPITAL MANAGEMENT, LLC first disclosed a stake in KURA in Q3 2023 at 350,445 shares (US$3.2M). The position peaked in Q2 2026 at 2,167,938 shares, worth US$23.8M. Across 13 filings, ALETHEA CAPITAL MANAGEMENT, LLC increased the stake 8 time(s), trimmed it 2 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 2,175,838 shares valued at US$23.3M. Notable position changes include a 108% increase in Q3 2024 (shares fell 55% over the following quarter), a 84% trim in Q3 2025 (shares rose 17% over the following quarter), a 848% increase in Q4 2025 (shares fell 22% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 350.44K | $3.20M | New |
| Q4 2023 | 350.44K | $5.04M | Hold |
| Q1 2024 | 259.61K | $5.54M | Reduce |
| Q2 2024 | 265.91K | $5.48M | Add |
| Q3 2024 | 553.54K | $10.82M | Add |
| Q4 2024 | 558.44K | $4.86M | Add |
| Q1 2025 | 659.18K | $4.35M | Add |
| Q2 2025 | 949.28K | $5.48M | Add |
| Q3 2025 | 150.00K | $277.50K | Reduce |
| Q4 2025 | 1.42M | $14.78M | Add |
| Q1 2026 | 1.53M | $12.43M | Add |
| Q2 2026 | 2.17M | $23.78M | Add |
| Q3 2026 | 2.18M | $23.30M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KURA and 13F data
KURA (KURA ONCOLOGY INC) is a Health Care company. 26 other funds we track also report a position in KURA — the largest reported positions include MONTANOVA CAPITAL, LLC (US$94.1M), BVF INC/IL (US$92.7M), ARMISTICE CAPITAL, LLC (US$40.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KURA
- MONTANOVA CAPITAL, LLC 8.58M sh · $94.07M · Q2 2026
- BVF INC/IL 8.45M sh · $92.65M · Q2 2026
- ARMISTICE CAPITAL, LLC 3.68M sh · $40.35M · Q2 2026
- Prosight Management, LP 2.02M sh · $22.18M · Q2 2026
- NAN FUNG TRINITY (HK) Ltd 1.17M sh · $12.58M · Q3 2026
More on ALETHEA CAPITAL MANAGEMENT, LLC
FAQ
How long has ALETHEA CAPITAL MANAGEMENT, LLC held KURA?
ALETHEA CAPITAL MANAGEMENT, LLC has disclosed KURA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is ALETHEA CAPITAL MANAGEMENT, LLC's current position in KURA?
As of Q3 2026, ALETHEA CAPITAL MANAGEMENT, LLC holds 2.18M shares of KURA (KURA ONCOLOGY INC), valued at $23.30M, representing 11.86% of its reported portfolio and ranking #3.
Has ALETHEA CAPITAL MANAGEMENT, LLC been buying or selling KURA?
In the latest 13F filing (Q3 2026), ALETHEA CAPITAL MANAGEMENT, LLC held unchanged its position in KURA. The position peaked in Q2 2026 at 2.17M shares.
Which other funds hold KURA?
Other major institutional holders of KURA include MONTANOVA CAPITAL, LLC, BVF INC/IL, ARMISTICE CAPITAL, LLC, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.